Investor Attys Seek $8.5M In $43M Medtronic Stock-Drop Deal
Law360 (October 30, 2018, 5:57 PM EDT) -- Counsel for a class of Medtronic Inc. investors asked a Minnesota federal judge on Monday for $8.5 million in fees and expenses for their work in reaching a $43 million settlement over claims the medical device maker manipulated studies for one of its products.
Attorneys from Robbins Geller Rudman & Dowd LLP and Motley Rice LLC said that they spent 35,300 hours litigating the case and reaching the settlement for a class of investors alleging Medtronic hid multimillion-dollar payments to researchers who helped conceal the risks associated with its Infuse bone graft technology.
"Lead counsel firmly believe that the settlement obtained...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!